Breakthrough helps develop novel painkillers
Washington: A breakthrough has opened the door for the development of a new category of painkillers which may be effective in treating pain related to a number of conditions including cancer, AIDS, migraines and diabetes.
The painkillers, called TRPV1 antagonists, can be activated by pepper like chemicals and high temperatures.
These drugs block the TRPV1 channel, which is the same receptor responsible for the sensation of hotness from hot peppers.
However, clinical trials have revealed that TRPV1 antagonists cause hyperthermia, which is a dangerous, fever-like rise in body temperature.
The same channel is responsible for pain caused by these diverse stimuli. For a number of years, scientists have focused on the development of TRPV1 antagonists, but have been stymied by the dangerous hyperthermia side-effect.
The ground breaking project to eliminate the side-effect was led by Andrej A. Romanovsky at Barrow Neurological Institute at St. Joseph`s Hospital and Medical Centre in Arizona and included researchers from Arizona State University.
"We think we have found a recipe for making TRPV1 antagonists that do not have this fever-like side effect," says Romanovsky.
More from India
More from World
More from Sports
More from Entertaiment
- ISIS threat: Home Ministry holds meeting with 12 state DGPs
- Delhi: Doctor found dead in RML hospital's parking lot
- SP leader seeks RS seat for Yakub's wife, sacked
- Playing politics on terror: Is this how the govt will combat terrorism?
- Exclusive chat with Bajrangi Bhaijaan's Munni aka Harshaali Malhotra
- India, Bangladesh swap border enclaves, settle historic dispute; people rejoice
- Watch: Passenger plane dangerously oscillates before touching runway
- Home Ministry holds high-level meet over ISIS
- Indian Army finds cow bombs near border, Maoists hand suspected?
- Yakub Memon's execution: Supreme Court Deputy Registrar quits over judgement